Surgical Site Infections Market Size To Hit US$ 1,138.9 Million By 2033
According to IMARC Group’s latest report, titled “Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”, the 7 major surgical site infections markets reached a value of US$ 630.0 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 1,138.9 Million by 2033, exhibiting a growth rate (CAGR) of 5.53% during 2023-2033. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Industry Definition and Application:
Surgical site infections (SSI) refer to medical complication that arises after surgery in the area of the body where the operation was conducted. It is primarily caused by the colonization of a surgical incision by infectious agents, like bacteria or fungi. SSI manifests as either a superficial condition simply affecting the skin or as a severe infection damaging the organs, implanted materials, or tissues beneath the skin. Some of the common symptoms of this ailment include redness, pain, fever, delayed healing, tenderness, swelling, and the drainage of cloudy fluid or pus from the wound site. The diagnosis of surgical site infections involves a combination of the patient’s medical history, clinical features, laboratory studies, the collection of wound swabs to determine the presence of disease-causing microorganisms, and ultrasonography.
Request for a Free Sample Copy of this Report:
https://www.imarcgroup.com/surgical-site-infections-market/requestsample
The growing instances of exogenous and endogenous infections caused by contamination of the operative site by microorganisms during the surgical procedure are primarily driving the surgical site infections (SSI) market. Additionally, the rising cases of various risk-associated factors, such as increased surgical duration, certain co-morbidities like diabetes and cancer, a weakened immune system, etc., are further catalyzing the market growth.
Moreover, the escalating utilization of antibiotic drugs, including cefazolin, metronidazole, vancomycin, clindamycin, etc., for treating the condition, as these medications destroy or slow down the proliferation of infection-causing germs, is creating a positive outlook for the market. Besides this, the rising popularity of combination therapies such as nasal mupirocin and a chlorhexidine body wash, owing to their ability to decolonize patients with bacterial growth and minimize the risk of microbial contamination, is anticipated to propel the surgical site infections (SSI) market in the coming years.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the surgical site infections market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the surgical site infections market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current surgical site infections marketed drugs and late-stage pipeline drugs.
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7365&flag=C
Competitive Landscape With Key Players:
The competitive landscape of the surgical site infections market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2033)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
